BioprintingCareer Moves

CELLINK brings on Distinguished Scientist Dr. Mina Bissell to advisory board

Dr. Bissell will contribute with unique experience in cancer research

Dr. Mina Bissell has joined the Advisory Board at 3D bioprinter manufacturer CELLINK and will contribute to the company’s development within cancer research and focus on developing technologies advancing the field. The Iranian born scientist runs the Bissell Lab at Lawrence Berkeley National Laboratory and has been recognized for her lifetime contributions to the fields of breast cancer research, the enhanced role of extracellular matrix (ECM) and the nucleus environment to gene expression in normal and malignant tissues. These works have ushered and have changed some central paradigms that have strengthened the importance of context in the development of cancer.

In addition, she was named Distinguished Scientist, the highest rank bestowed at Lawrence Berkeley National Laboratory (LBNL), and serves as Senior Advisor to the Laboratory Director on Biology. She is also Faculty of four Graduate Groups in UC Berkeley: Comparative Biochemistry, Endocrinology, Molecular Toxicology, and Bioengineering (UCSF/UCB joint program).

Dr. Mina Bissell joins CELLINK

Having challenged several established paradigms, Bissell is a pioneer in breast cancer research and her body of work has provided much impetus for the current recognition of the significant role that extracellular matrix (ECM) signaling and microenvironment play in gene expression regulation in both normal and malignant cells. Her laboratory developed novel 3D assays and techniques that demonstrate her signature phrase: after conception, “phenotype is dominant over genotype.”

As the company continues to enjoy rapid growth, the CELLINK advisory board now consist of 4 advisors who have covered and continue to cover highly relevant positions in the medical industry and academia. Rolf Claesson served as Chairman of Bayer HealthCare and Tecan Group, as well as CEO of Bayer Diagnostics. Dr. Ali Khademhosseini, served as Professor at Harvard-MIT, Brigham and Women’s Hospital and Harvard Medical School. Dr. David Williams is a Professor at Wake Forest School of Medicine and is regarded as a leading authority on biomaterials, medical devices, and biocompatibility. He authored and co-authored over 400 technical papers within his field of expertise.


Davide Sher

Since 2002, Davide has built up extensive experience as both a technology journalist and communications consultant. Born in Milan, Italy, he spent 12 years in the United States, where he received his undergraduate degree from SUNY Stony Brook. He is a senior analyst for US-based firm SmarTech Publishing focusing on the additive manufacturing industry. He founded London-based 3D Printing Business Media Ltd. (now 3dpbm) which specializes in marketing, editorial and market analysys&consultancy services for the additive manufacturing industry. 3dpbm publishes 3D Printing Business Directory, the largest global directory of companies related to 3DP, as well as several editorial websites, including 3D Printing Media Network and Replicatore.

Related Articles

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services